Publications by authors named "David Parr"

Claim this Profile
M
Modification of the course of disease progression in idiopathic pulmonary fibrosis by pirfenidone: evidence of the potential for disease reversal.
Alexander Herrmann, David Parr

BMJ Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypervitaminosis B12: an indicator of potential significant morbidity.
Muzammil Munnawar Saeed, David Parr

BMJ Case Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative BAL: a suitable method for the assessment of epithelial lining fluid in alpha-1 antitrypsin deficiency?
David G Parr

Thorax· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitrypsin deficiency: still more to learn about the lung after 60 years.
Robert A Stockley, David G Parr

ERJ Open Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CT-Derived Measurement of Sarcopenia Fails to Predict Falls.
Setu Dalal, Scarlett Tucker, Tania Zielonka, JacqueLyn Kinney, Andrew Magdich, David Parr

Am Surg· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry.
Marc Miravitlles, Alice M Turner, María Torres-Duran, Hanan Tanash, Carlota Rodríguez-García, David G Parr

Eur Respir J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
Marc Miravitlles, Alice M Turner, María Torres-Duran, Hanan Tanash, Carlota Rodríguez-García, David G Parr

Respir Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration.
David G Parr, Joanna Chorostowska-Wynimko, Angelo Corsico, Cristina Esquinas, Gerard N McElvaney

Arch Bronconeumol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
Marc Miravitlles, Alice M Turner, María Torres-Duran, Hanan Tanash, Carlota Rodríguez-García, David G Parr

Respir Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing the cause of pulmonary infiltrates in an acutely unwell patient.
Monika Urszula Kolejwa, Oludolapo Adesanya, David Parr

BMJ Case Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
Mohammadali Yavari Ramsheh, Koirobi Haldar, Anna Esteve-Codina, Lillie F Purser, Matthew Richardson, David G Parr

Lancet Microbe· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes.
Anna Esteve-Codina, Thomas P Hofer, Dorothe Burggraf, Marion S Heiss-Neumann, Wolfgang Gesierich, David G Parr

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive photopatch test to pirfenidone.
Emily Forbat, David Parr, Tang Ngee Shim

Contact Dermatitis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Recommendations on the Use of F-FDG PET/CT in Lung Disease.
Delphine L Chen, Safia Ballout, Laigao Chen, Joseph Cheriyan, Gourab Choudhury, David Parr

J Nucl Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Hassan Kahal, Ioannis Kyrou, Olalekan A Uthman, Anna Brown, Samantha Johnson, David G Parr

Sleep Breath· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulminating deep tissue space infection with presenting initially as a sore throat.
Joe Glover, Gorana Kovacevic, Gary Walton, David Parr

BMJ Case Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.
Leena George, Adam R Taylor, Anna Esteve-Codina, María Soler Artigas, Gian Andri Thun, David G Parr

Allergy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the EARCO Registry: a pan-European observational study in patients with α-antitrypsin deficiency.
Timm Greulich, Alan Altraja, Miriam Barrecheguren, Robert Bals, Jan Chlumsky, David Parr

ERJ Open Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controls.
Gian-Andri Thun, Sophia Derdak, Francesc Castro-Giner, Katherine Apunte-Ramos, Lidia Águeda, David G Parr

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.
Berend C Stoel, Jan Stolk, M Els Bakker, David G Parr

Respir Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
David G Parr, Beatriz Lara

Drug Des Devel Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α-antitrypsin deficiency.
Marc Miravitlles, Asger Dirksen, Ilaria Ferrarotti, Vladimir Koblizek, Peter Lange, David Parr

Eur Respir J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of exercise duration on cardiorespiratory responses, energy cost and tissue oxygenation within a 6 hour treadmill run.
Hugo A Kerhervé, Scott McLean, Karen Birkenhead, David Parr, Colin Solomon

PeerJ· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the Lung at Risk in Chronic Obstructive Pulmonary Disease. Does Emphysema Beget Emphysema?
David G Parr

Am J Respir Crit Care Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.
Marion Engel, David Endesfelder, Brigitte Schloter-Hai, Susanne Kublik, Michael S Granitsiotis, David Parr

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis